Compare Agilent Technologies Inc (A) vs GE Vernova Inc (GEV) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs GE Vernova Inc — how do they compare? Agilent Technologies Inc trades at $128.2 (market cap $37.04B), while GE Vernova Inc trades at $1,085.4 (market cap $289.43B). The key difference: GE Vernova Inc is far larger — about 7.8× Agilent Technologies Inc's market cap, and Agilent Technologies Inc pays the higher dividend (0.78%). Which is the better fit depends on your goals.
| A | GEV | |
|---|---|---|
Market Cap | $37.04B | $289.43B |
Sector | Health | Technology |
52-Week High | $157.20 | $1.17K |
52-Week Low | $110.24 | $530.00 |
Enterprise Value | $38.59B | $282.07B |
Dividend Yield | 0.78% | 0.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
GE Vernova (GEV) trades at $1,152.04, up 3.5% with strong bullish technical signals and robust fundamentals. The stock shows impressive profitability with 23.81% net margin and 83.23% ROE, though valuations appear elevated with P/E of 33.67. Recent earnings beat expectations in Q4 2025 and Q1 2026, while Q2 2026 estimates await. The company benefits from AI infrastructure demand, with gas turbines powering data centers driving growth.
Outlook remains positive given AI-driven power infrastructure demand and raised 2026 guidance, but premium valuation and execution risks warrant caution. Analyst consensus strongly favors buying with $1,220 price target, representing 6% upside. Key risks include valuation sensitivity and competitive pressures in energy transition markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About GE Vernova Inc
GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.
Read more on GEV →
